Eli Lilly (LLY) EBT Margin (2009 - 2026)

Eli Lilly has reported EBT Margin for 18 years, with the latest figure at 44.7% in Q1 2026.

• For the quarter ending Q1 2026, EBT Margin rose 1755.0% year-over-year to 44.7%; the trailing twelve-month figure through Mar 2026 stood at 43.08% (up 1533.0% YoY), and the FY2025 full-year result was 39.48%, up 1133.0% from the prior year.
• EBT Margin for Q1 2026 stood at 44.7%, up from 42.85% in the prior quarter.
• The five-year high for EBT Margin was 44.7% in Q1 2026, with the low at 4.5% in Q3 2023.
• Historically, EBT Margin has averaged 28.43% across 5 years, with a median of 27.15% in 2025.
• Annual changes were most pronounced in 2023 — EBT Margin plunged 1805 bps — and 2025, when it surged 2721 bps.
• Eli Lilly's EBT Margin stood at 28.71% in 2022, then declined by 7 bps to 26.82% in 2023, then soared by 39 bps to 37.23% in 2024, then advanced by 15 bps to 42.85% in 2025, then rose by 4 bps to 44.7% in 2026.
• The last three EBT Margin figures came in at 44.7% (Q1 2026), 42.85% (Q4 2025), and 41.09% (Q3 2025), per Business Quant data.